Nutex Health, Inc.
NUTXNASDAQHealthcare● Active
$134.41
+$1.82(+1.37%)
Market Cap$800320958
P/E Ratio—
52W High$193.07
52W Low$77.21
Nutex Health, Inc. (NUTX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NUTX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.88B | $0.48B | $0.25B | $0.22B | $0.33B |
| Cost of Revenue | $0.43B | $0.28B | $0.21B | $0.20B | $0.15B |
| Gross Profit | $0.44B | $0.20B | $0.03B | $0.02B | $0.18B |
| Gross Margin %(computed) | 50.76% | 40.89% | 14.04% | 7.03% | 54.08% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.17B | $0.06B | $0.03B | $0.02B | $0.01B |
| Total Operating Expenses | $0.17B | $0.07B | $0.07B | $0.42B | $0.01B |
| Operating Income | $0.28B | $0.13B | ($0.03B) | ($0.41B) | $0.17B |
| Operating Margin %(computed) | 31.49% | 27.22% | -12.83% | -185.41% | 51.36% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.02B | $0.01B | $0.01B |
| Income Before Tax | $0.24B | $0.11B | ($0.05B) | ($0.42B) | $0.17B |
| Income Tax Expense | $0.06B | $0.01B | ($0.01B) | $0.01B | $0.00B |
| Net Income | $0.07B | $0.05B | ($0.05B) | ($0.42B) | $0.13B |
| Net Margin %(computed) | 8.09% | 10.87% | -18.49% | -193.70% | 39.99% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $11.13 | $10.23 | $-10.39 | $-100.50 | $33.55 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B |
| EBITDA | $0.29B | $0.15B | ($0.01B) | ($0.39B) | $0.18B |
| EBITDA Margin %(computed) | 32.85% | 30.97% | -5.89% | -179.68% | 55.33% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Nutex Health, Inc. data
About Nutex Health, Inc. (NUTX) Income Statement
Nutex Health, Inc. (NUTX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NUTX reported revenue of $0.88B, gross profit of $0.44B (gross margin 50.76%), and net income of $0.07B — a net profit margin of 8.09%.
Frequently asked questions
NUTX · 4 questionsNutex Health, Inc. (NUTX) reported revenue of $0.88B for 2025, up 82.4% year-over-year.
NUTX revenueNUTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08